Albertsons Companies (ACI)
NYSE:ACI
Want to see ACI full AI Analyst Report?
ACI Stock Chart & Stats
$16.70
$0.02(0.10%)
At close: 4:00 PM EST
$16.70
$0.02(0.10%)
Day’s Range― - ―
52-Week Range$15.80 - $22.78
Previous CloseN/A
Volume3.94M
Average Volume (3M)7.09M
Market Cap
$8.22B
Enterprise Value$23.15B
Total Cash (Recent Filing)$198.60M
Total Debt (Recent Filing)$15.30B
Price to Earnings (P/E)44.9
Beta0.05
Next Earnings
Jul 28, 2026EPS Estimate
0.54Next Dividend Ex-DateN/A
Dividend Yield3.49%
Share Statistics
EPS (TTM)0.32
Shares Outstanding494,534,850
10 Day Avg. Volume9,462,748
30 Day Avg. Volume7,094,197
Financial Highlights & Ratios
PEG Ratio-0.59
Price to Book (P/B)5.31
Price to Sales (P/S)0.12
P/FCF Ratio18.51
Enterprise Value/Market Cap2.82
Enterprise Value/Revenue0.28
Enterprise Value/Gross Profit1.04
Enterprise Value/Ebitda6.77
Forecast
1Y Price Target
$21.27Price Target Upside27.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)2.27
Revenue Forecast (FY)$82.49B
Bulls Say, Bears Say
Bulls Say
Digital Growth And Loyalty EngagementExpansion of the loyalty program and stronger digital sales and engagement is shifting the sales mix toward higher-margin channels and aiding customer retention.
Earnings StabilityAdjusted EBITDA appears to be stabilizing after several years of declines, supporting an improving profit outlook that could increase investor confidence.
Productivity-funded Pricing StrategyScaling of productivity initiatives to fund targeted price investments and reduce operating costs should help protect margins and support ongoing profitability improvement.
Bears Say
Fulfillment Costs And Margin CompressionHigher digital fulfillment costs and ongoing price investments have narrowed gross margins, with productivity gains only partially offsetting the pressure.
Pharmacy Demand WeaknessSharper-than-expected declines in pharmacy demand and a shift in pharmacy mix are weighing on overall sales momentum and pressuring top-line growth.
Regulatory Drug-pricing PressurePolicy-driven lower drug pricing and an increased shift toward generic prescriptions are reducing pharmacy revenue growth and creating headwinds for sales.
Albertsons Companies News
ACI FAQ
What was Albertsons Companies’s price range in the past 12 months?
Albertsons Companies lowest stock price was $15.80 and its highest was $22.78 in the past 12 months.
What is Albertsons Companies’s market cap?
Albertsons Companies’s market cap is $8.22B.
When is Albertsons Companies’s upcoming earnings report date?
Albertsons Companies’s upcoming earnings report date is Jul 28, 2026 which is in 84 days.
How were Albertsons Companies’s earnings last quarter?
Albertsons Companies released its earnings results on Apr 14, 2026. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.05.
Is Albertsons Companies overvalued?
According to Wall Street analysts Albertsons Companies’s price is currently Undervalued.
Does Albertsons Companies pay dividends?
Albertsons Companies pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 3.49%. See more information on Albertsons Companies dividends here
What is Albertsons Companies’s EPS estimate?
Albertsons Companies’s EPS estimate is 0.54.
How many shares outstanding does Albertsons Companies have?
Albertsons Companies has 494,534,850 shares outstanding.
What happened to Albertsons Companies’s price movement after its last earnings report?
Albertsons Companies reported an EPS of $0.48 in its last earnings report, beating expectations of $0.43. Following the earnings report the stock price went down -3.028%.
Which hedge fund is a major shareholder of Albertsons Companies?
Currently, no hedge funds are holding shares in ACI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Albertsons Companies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.27 (27.38% Upside)
$21.27 (27.38% Upside)
Blogger Sentiment
Bullish
ACI Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $761.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.9%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.68%
12-Months-Change
Fundamentals
Return on Equity
8.17%
Trailing 12-Months
Asset Growth
0.63%
Trailing 12-Months
Company Description
Albertsons Companies
Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States. The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores. As of February 26, 2022, it operated 2,276 stores under various banners, including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets, and Balducci's Food Lovers Market; and 1,722 pharmacies, 1,317 in-store branded coffee shops, 402 adjacent fuel centers, 22 distribution centers, and 20 manufacturing facilities, as well as various digital platforms. The company was founded in 1860 and is headquartered in Boise, Idaho.
ACI Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call balanced clear evidence of operational progress — strong adjusted EBITDA and EPS performance, digital and loyalty momentum, an upgraded $2.0B productivity program, continued shareholder returns, and a manageable leverage profile — against material near-term retail and pharmacy headwinds (IRA-driven pharmacy pressure, GLP-1 moderation, unit pressure in lower-income cohorts, egg deflation and a recorded $774M opioid settlement framework). Management presented a constructive FY26 outlook with modest EBITDA and EPS growth, continued investment in AI/technology and an expanded share-repurchase authorization while acknowledging a challenging Q1 cadence. Overall, positives around productivity, digital/loyalty scale and capital allocation appear to outweigh the near-term challenges, with leadership confidence that investments and AI-driven initiatives will drive sequential improvement through the year.View all ACI earnings summariesACI Stock 12 Month Forecast
Average Price Target
$21.27
▲(27.38% Upside)
Technical Analysis
Ingles Markets
―
Kroger Company
―
Weis Markets
―
Sprouts Farmers
―
Grocery Outlet Holding
―
Ownership Overview
1.21% Insiders
17.88% Mutual Funds
1.20% Other Institutional Investors
61.88% Public Companies and
Individual Investors